DHS Secretary Mullin shares alarming theory that AI may have sparked recent chaos at airports and banks
Reserve Bank boss Michele Bullock delivers tough message to mortgage holders after five rate hikes – saying she’s more worried about renters
What exactly is a light-day? Here’s what Voyager 1’s latest milestone means for the interstellar probe
HomeMarketVivos Therapeutics GAAP EPS of -$0.07 beats by $0.25, revenue of $6.41M beats by $0.94M Posted in Market Vivos Therapeutics GAAP EPS of -$0.07 beats by $0.25, revenue of $6.41M beats by $0.94M November 17, 2026 Reporter Vivos Therapeutics GAAP EPS of -$0.07 beats by $0.25, revenue of $6.41M beats by $0.94M Source link
Barfresh signals $20M-$22M FY 2026 revenue and expects positive adjusted EBITDA in Q4 as Defiance plant targets early to mid-2027 start Posted by Reporter
DHS Secretary Mullin shares alarming theory that AI may have sparked recent chaos at airports and banks